Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocurcumin in Prostate Cancer Radiotherapy
NCT02724618Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SinaCurcumin in prostate cancer (PCa), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
SinaCurcumin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02724618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724618.